Dihydroergotamine Completed Phase 1 / 2 Trials for Healthy Volunteers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01191723QT Intervals Study to Compare the Acute Effects of Orally Inhaled Dihydroergotamine (DHE), Oral Moxifloxacin, and Placebo
NCT01468558Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With Ketoconazole
NCT01089062Pharmacodynamic Study to Compare Acute Effects of Dihydroergotamine Mesylate (DHE) on Pulmonary Arterial Pressure